Company / Net Income
RHYTHM PHARMACEUTICALS, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$196.5M
FY2025
5-year range
-$260.6M / -$69.6M
FY2021-FY2025
Trend
+24.6%
vs FY2024
Sector context
#154 of 216
Health Care
What the data says
At -$197M, RHYTHM PHARMACEUTICALS, INC.'s net income ranks #154 of 216 in the Health Care sector. Net Income returned to growth in FY2025 after 3 years of decline, reaching -$197M.
Based on SEC 10-K filings.
-$197M in FY2025.
Declined from -$185M to -$197M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#154 of 216 in Health CareTop 71% of 216This company -$196.5M Sector average $454.3M
▼
-143.3% below sector average
Key checks
Key Insights
- In FY2025, net income increased 24.6% year-over-year.
- Ranks #154 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$196.5M | +24.6% |
| FY2024 | -$260.6M | -41.1% |
| FY2023 | -$184.7M | -2.0% |
| FY2022 | -$181.1M | -160.2% |
| FY2021 | -$69.6M | +48.0% |
| FY2020 | -$134.0M | +4.8% |
| FY2019 | -$140.7M | -90.0% |
| FY2018 | -$74.1M | -119.7% |
| FY2017 | -$33.7M | -30.3% |
| FY2016 | -$25.9M | -133.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026